Survodutide
A Study to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body When Given by Injection in Healthy Men and Women With and Without Overweight or Obesity
Boehringer Ingelheim · Phase 1 · Active, not recruiting · Enrollment 44
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| BI 456906 formulation A (Reference) then BI 456906 formulation B2 (Test) | n/r | n/r | n/r | n/r | n/r |
| BI 456906 formulation B2 (Test) then BI 456906 formulation A (Reference) | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.